重型COVID-19脑白质病的临床、影像与实验室相关性
连续纳入27例入住ICU后行脑MR的SARS-CoV-2阳性患者,7例(26%)出现弥散受限型脑白质病。该组BMI更高,最低血红蛋白更低、血钠更高,并呈高度可重复的对称性幕上及小脑中脚白质病变分布。
要点
- ICU新冠患者出现对称性幕上及小脑中脚白质病变伴弥散受限,应警惕重型COVID-19脑白质病。
- 该影像模式与肥胖、急性肾衰竭、轻度高钠血症及贫血存在相关性。
- 弥散受限组最低血红蛋白更低、血钠更高,提示电解质转运障碍及分水岭缺血可能参与。
核心结论
- 重型COVID-19伴弥散受限的脑白质病与肥胖、急性肾衰竭、轻度高钠血症、贫血及特殊脑MR白质病变分布模式存在显著相关性。
- 上述观察可能为SARS-CoV-2相关脑白质病的病理生理机制(分水岭缺血、电解质转运障碍、沉默性缺氧合并细胞因子风暴)提供线索。
研究设计与样本
- 研究类型为对连续病例的临床、实验室与神经影像学比较分析。
- 纳入27例SARS-CoV-2阳性且入住ICU后行脑MR检查的患者。
- 7例(7/27,26%)在弥散加权MR上出现「弥散受限型脑白质病」模式,其余患者无此模式。
- 比较两组临床指标、实验室指标及神经影像学表现。
关键影像表现/征象
- 弥散受限组呈现高度可重复的融合性、以对称性为主的幕上及小脑中脚白质病变分布(P < .001)。
- 弥散受限组平均BMI为36 kg/m2,高于无弥散受限组的28 kg/m2(P < .01)。
- MRI时弥散受限组急性肾衰竭比例7/7(100%),无弥散受限组9/20(45%),P = .06。
- MRI时弥散受限组估算肾小球滤过率49 mL/min,低于无弥散受限组的85 mL/min(P = .06)。
- MR前24小时内弥散受限组最低血红蛋白均值8.1 g/dL,低于无弥散受限组的10.2 g/dL(P < .05);弥散受限组血清钠147 mmol/L,高于无弥散受限组的139 mmol/L(P = .04)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Patients infected with the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) can develop a spectrum of neurological disorders, including a leukoencephalopathy of variable severity. Our aim was to characterize imaging, lab, and clinical correlates of severe coronavirus disease 2019 (COVID-19) leukoencephalopathy, which may provide insight into the SARS-CoV-2 pathophysiology.
MATERIALS AND METHODS: Twenty-seven consecutive patients positive for SARS-CoV-2 who had brain MR imaging following intensive care unit admission were included. Seven (7/27, 26%) developed an unusual pattern of "leukoencephalopathy with reduced diffusivity" on diffusion-weighted MR imaging. The remaining patients did not exhibit this pattern. Clinical and laboratory indices, as well as neuroimaging findings, were compared between groups.
RESULTS: The reduced-diffusivity group had a significantly higher body mass index (36 versus 28 kg/m2, P < .01). Patients with reduced diffusivity trended toward more frequent acute renal failure (7/7, 100% versus 9/20, 45%; P = .06) and lower estimated glomerular filtration rate values (49 versus 85 mL/min; P = .06) at the time of MRI. Patients with reduced diffusivity also showed lesser mean values of the lowest hemoglobin levels (8.1 versus 10.2 g/dL, P < .05) and higher serum sodium levels (147 versus 139 mmol/L, P = .04) within 24 hours before MR imaging. The reduced-diffusivity group showed a striking and highly reproducible distribution of confluent, predominantly symmetric, supratentorial, and middle cerebellar peduncular white matter lesions (P < .001).
CONCLUSIONS: Our findings highlight notable correlations between severe COVID-19 leukoencephalopathy with reduced diffusivity and obesity, acute renal failure, mild hypernatremia, anemia, and an unusual brain MR imaging white matter lesion distribution pattern. Together, these observations may shed light on possible SARS-CoV-2 pathophysiologic mechanisms associated with leukoencephalopathy, including borderzone ischemic changes, electrolyte transport disturbances, and silent hypoxia in the setting of the known cytokine storm syndrome that accompanies severe COVID-19.
引用
- Rapalino O, Pourvaziri A, Maher M, et al. Clinical, Imaging, and Lab Correlates of Severe COVID-19 Leukoencephalopathy. AJNR Am J Neuroradiol. 2021. PMID: 33414226. doi:10.3174/ajnr.A6966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。